Arcadia Biosciences Inc
RKDA3.040USD
-0.170-5.30%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
4.16MMarket Cap
LossP/E TTM
More Details of Arcadia Biosciences Inc Company
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.
Arcadia Biosciences Inc Info
Ticker SymbolRKDA
Company nameArcadia Biosciences Inc
IPO dateMay 15, 2015
CEOSchaefer (Thomas J)
Number of employees9
Security typeOrdinary Share
Fiscal year-endMay 15
Address5956 Sherry Lane
CityDALLAS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code75225
Phone12149748921
Websitehttps://arcadiabio.com/
Ticker SymbolRKDA
IPO dateMay 15, 2015
CEOSchaefer (Thomas J)
Company Executives of Arcadia Biosciences Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas J. Schaefer
Mr. Thomas J. Schaefer
President, Chief Executive Officer, Interim Chief Financial Officer
President, Chief Executive Officer, Interim Chief Financial Officer
--
--
Dr. Albert D. Bolles, Ph.D.
Dr. Albert D. Bolles, Ph.D.
Independent Director
Independent Director
--
--
Ms. Lilian Shackleford Murray
Ms. Lilian Shackleford Murray
Independent Director
Independent Director
--
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Ms. Amy J. Yoder
Ms. Amy J. Yoder
Independent Director
Independent Director
--
--
Mr. Kevin J. Comcowich
Mr. Kevin J. Comcowich
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Deborah D. (Debbie) Carosella
Ms. Deborah D. (Debbie) Carosella
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas J. Schaefer
Mr. Thomas J. Schaefer
President, Chief Executive Officer, Interim Chief Financial Officer
President, Chief Executive Officer, Interim Chief Financial Officer
--
--
Dr. Albert D. Bolles, Ph.D.
Dr. Albert D. Bolles, Ph.D.
Independent Director
Independent Director
--
--
Ms. Lilian Shackleford Murray
Ms. Lilian Shackleford Murray
Independent Director
Independent Director
--
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Ms. Amy J. Yoder
Ms. Amy J. Yoder
Independent Director
Independent Director
--
--
Mr. Kevin J. Comcowich
Mr. Kevin J. Comcowich
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
4.90M
97.19%
Canada
109.00K
2.16%
Argentina
26.00K
0.52%
India
7.00K
0.14%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.95%
Mariner Wealth Advisors
0.89%
State Street Investment Management (US)
0.88%
DRW Securities, LLC
0.73%
Other
95.52%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.95%
Mariner Wealth Advisors
0.89%
State Street Investment Management (US)
0.88%
DRW Securities, LLC
0.73%
Other
95.52%
Shareholder Types
Shareholders
Proportion
Investment Advisor
2.73%
Investment Advisor/Hedge Fund
1.83%
Individual Investor
0.82%
Hedge Fund
0.12%
Research Firm
0.08%
Other
94.42%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
30
58.96K
4.31%
-249.34K
2025Q2
35
87.93K
6.43%
-234.13K
2025Q1
38
87.93K
6.43%
-244.41K
2024Q4
49
156.69K
11.48%
-110.76K
2024Q3
49
100.21K
9.85%
-202.17K
2024Q2
47
71.82K
7.77%
-229.97K
2024Q1
51
258.53K
25.32%
-38.12K
2023Q4
56
321.69K
30.80%
+98.94K
2023Q3
62
165.26K
19.23%
-273.71K
2023Q2
66
255.84K
27.41%
-81.95K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
14.04K
1.03%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
12.79K
0.94%
--
--
Jun 30, 2025
Mariner Wealth Advisors
14.50K
1.06%
-12.98K
-47.24%
Jun 30, 2025
State Street Investment Management (US)
12.15K
0.89%
--
--
Jun 30, 2025
Jacot (Stanley Jr)
5.00K
0.37%
--
--
Mar 31, 2025
Schaefer (Thomas J.)
2.82K
0.21%
--
--
Mar 31, 2025
Kawakami (Mark)
2.68K
0.2%
--
--
Mar 31, 2025
Tower Research Capital LLC
1.92K
0.14%
+1.48K
+338.22%
Jun 30, 2025
UBS Financial Services, Inc.
2.51K
0.18%
-6.02K
-70.57%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Date
Type
Ratio
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
FAQs
Who are the top five shareholders of Arcadia Biosciences Inc?
The top five shareholders of Arcadia Biosciences Inc are:
The Vanguard Group, Inc. holds 14.04K shares, accounting for 1.03% of the total shares.
Geode Capital Management, L.L.C. holds 12.79K shares, accounting for 0.94% of the total shares.
Mariner Wealth Advisors holds 14.50K shares, accounting for 1.06% of the total shares.
State Street Investment Management (US) holds 12.15K shares, accounting for 0.89% of the total shares.
Jacot (Stanley Jr) holds 5.00K shares, accounting for 0.37% of the total shares.
The Vanguard Group, Inc. holds 14.04K shares, accounting for 1.03% of the total shares.
Geode Capital Management, L.L.C. holds 12.79K shares, accounting for 0.94% of the total shares.
Mariner Wealth Advisors holds 14.50K shares, accounting for 1.06% of the total shares.
State Street Investment Management (US) holds 12.15K shares, accounting for 0.89% of the total shares.
Jacot (Stanley Jr) holds 5.00K shares, accounting for 0.37% of the total shares.
What are the top three shareholder types of Arcadia Biosciences Inc?
The top three shareholder types of Arcadia Biosciences Inc are:
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Mariner Wealth Advisors
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Mariner Wealth Advisors
How many institutions hold shares of Arcadia Biosciences Inc (RKDA)?
As of 2025Q3, 30 institutions hold shares of Arcadia Biosciences Inc, with a combined market value of approximately 58.96K, accounting for 4.31% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -2.12%.
What is the biggest source of revenue for Arcadia Biosciences Inc?
In FY2024, the -- business generated the highest revenue for Arcadia Biosciences Inc, amounting to -- and accounting for --% of total revenue.
